Systemic misconduct and image manipulation in high-stakes biomedical fields distort evidence and priorities.
— Undermines trust in science, misallocates public and private funds, and affects patient outcomes and policy.
Jake Currie
2026.03.31
92% relevant
Hwang Woo‑suk’s fabricated stem‑cell work is a high‑profile example of biomedical fraud that the article uses to show how misconduct can rapidly reshape public hope, funding narratives, and regulatory scrutiny in medicine.
Scott Alexander
2025.08.14
75% relevant
The article confronts known fraudulent amyloid studies and contends the broader evidentiary base remains strong, engaging the wider concern that high-profile misconduct distorts fields and public trust in biomedical research.
Steve Sailer
2025.08.13
100% relevant
Article cites years of alleged fraud shaping Alzheimer’s research directions and results.
2023.07.18
90% relevant
The article documents and cites estimates (eg. John Carlisle’s 2020 work) and follow‑up investigations suggesting that in some fields up to ~25% of trials are suspicious or fabricated, directly exemplifying and updating the claim that biomedical research faces a systemic fraud problem.